Benzinga, founded in 2010 by Jason Raznick and headquartered in Detroit, Michigan, is a dynamic financial media and technology company dedicated to empowering individual investors with timely, actionable insights. Initially launched from Raznick’s basement with a modest $10,000 investment, the company has grown into a trusted resource, attracting approximately 25 million monthly readers through its innovative blend of real-time financial news, market analysis, and trading tools.
Sen. Bernie Sanders praised a bipartisan House vote overturning President Donald Trump's order limiting federal union rights, urged the Senate to pass the measure despite uncertain prospects, and tied the fight to broader labor disputes involving Starbucks and Amazon.
The Trump administration lifted Magnitsky sanctions on Brazilian Supreme Court Justice Alexandre de Moraes—who oversaw Jair Bolsonaro's coup-related conviction—as U.S.–Brazil trade tensions eased and diplomatic ties with President Luiz Inacio Lula da Silva warmed.
The Fed's third straight rate cut sparked sharp market rotation, cooling AI stocks while lifting small caps, precious metals, autos and non-tech leaders.
Berkshire Hathaway increased its position in four stocks in the third quarter. One of those bets is paying off nicely with the total stake up $830 million since Q3.
The global conversation around digital assets is shifting from speculative market cycles to deeper questions about blockchain surveillance, compliance and the future of privacy. As regulators intensify their focus on how cryptocurrency transactions are monitored, the stakes are rising for investors, builders and platforms that rely on decentralized technologies.
GameStop stock is trading lower this week, down approximately 7% over the past five days to sit near $21.50, as investors react to a mixed Q3 financial report.
Aardvark Therapeutics gains an Outperform rating as its Phase 3 PWS trial progresses and analysts point to large market potential for ARD-101 and ARD-201.
Heart disease-focused Tenaya Therapeutics falls on high volume after pricing a $60 million offering and releasing new TN-401 data, while the FDA clears the TN-201 trial hold.
EMA issues positive opinion on Novo Nordisk's higher-dose Wegovy, supported by strong weight-loss data and ongoing reviews in the U.S., U.K., and other markets.
FDA officials are weighing a black box warning for Covid vaccines, a proposal that has drawn strong criticism from outside experts citing lack of evidence.
